product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
CD4 Antibody (V46P5B10*D5) [PE]
catalog :
NBP2-50140PE
quantity :
0.1 ml
price :
469 USD
clonality :
monoclonal
host :
mouse
conjugate :
PE
clone name :
V46P5B10*D5
reactivity :
human
application :
ELISA
more info or order :
product information
brand :
Novus
master code :
NBP2-50140PE
SKU :
NBP2-50140PE
product name :
CD4 Antibody (V46P5B10*D5) [PE]
sizes available :
0.1 ml
description :
The CD4 Antibody (V46P5B10*D5) [PE] from NBP2-50140PE is a 6.3e-05 antibody to . This antibody reacts with fish.
target :
CD4
category :
Primary Antibodies
buffer :
PBS
clonality :
Monoclonal
clone :
V46P5B10*D5
conjugate :
PE
dilution :
ELISA
host :
Mouse
immunogen :
Ovalbumin-conjugated synthetic peptide
isotype :
IgG2b Kappa
purity :
Protein G purified
species :
Fish
specificity :
Specific for three-spined stickleback CD4.
gene symbol :
CD4
applications :
ELISA
USD :
469 USD
alt names :
CD_antigen: CD4, CD4, CD4 antigen, CD4 antigen (p55), CD4 molecule, CD4 receptor, CD4mut, T-cell surface antigen T4/Leu-3, T-cell surface glycoprotein CD4
storage :
Store at 4C in the dark.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
related products
browse more products
- Fc epsilon RI Antibody (IE7) [Alexa Fluor® 647] | NBP3-12051AF647
- EGFR Antibody (Matuzumab) [Allophycocyanin/Cy7] | NBP2-75911APCCY7
- KLRC1/2/3 Antibody (20d5) [Alexa Fluor® 700] | NBP1-28100AF700
- KLRC1/2/3 Antibody (20d5) [Alexa Fluor® 647] | NBP1-28100AF647
- KLRC1/2/3 Antibody (20d5) [Alexa Fluor® 594] | NBP1-28100AF594
questions and comments
